Solithromycin is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections.
Solithromycin is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections.
Investigated for the treatment of community-acquired pneumonia (CAP).
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.